Position history for BlackRock, Inc.'s holdings in SYNDAX PHARMACEUTICALS INC
BlackRock, Inc. holds 8.3M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $192.8M as of 2026-Q1. The position was increased (+0.2% shares). SNDX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$192.8M
Current Shares
8.3M
Total Value Change
+$73.4M
Total Shares Change
-779,523
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BlackRock Finance, Inc.
Increased |
| 8.3M |
+0.2% |
| $192.8M |
| 0.0% |
| $21.40 |
30 |
| 2025-Q4 | Decreased | 8.2M | -4.5% | $173.1M | 0.0% | $20.74 | 0 |
| 2025-Q3 | Decreased | 8.6M | -17.5% | $132.7M | 0.0% | $15.56 | 0 |
| 2025-Q2 | Increased | 10.5M | +22.4% | $97.9M | 0.0% | $9.04 | 36 |
| 2025-Q1 | Decreased | 8.5M | -5.4% | $104.9M | 0.0% | $13.18 | 0 |
| 2024-Q4 | New | 9M | - | $119.4M | 0.0% | $12.52 | 42 |